Geode Capital Management’s 89bio ETNB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-3,092,340
Closed -$45.5M 4499
2025
Q3
$45.5M Sell
3,092,340
-18,959
-0.6% -$193K ﹤0.01% 1533
2025
Q2
$30.6M Buy
3,111,299
+213,325
+7% +$1.77M ﹤0.01% 1716
2025
Q1
$21.1M Buy
2,897,974
+690,366
+31% +$6.04M ﹤0.01% 1872
2024
Q4
$17.3M Buy
2,207,608
+132,638
+6% +$1.09M ﹤0.01% 2046
2024
Q3
$15.4M Buy
2,074,970
+160,356
+8% +$1.35M ﹤0.01% 2130
2024
Q2
$15.3M Buy
1,914,614
+173,747
+10% +$1.55M ﹤0.01% 2076
2024
Q1
$20.3M Buy
1,740,867
+363,157
+26% +$4.02M ﹤0.01% 1919
2023
Q4
$15.4M Buy
1,377,710
+83,722
+6% +$770K ﹤0.01% 2068
2023
Q3
$20M Buy
1,293,988
+116,999
+10% +$1.96M ﹤0.01% 1819
2023
Q2
$22.3M Buy
1,176,989
+673,044
+134% +$11.8M ﹤0.01% 1779
2023
Q1
$7.68M Buy
503,945
+160,089
+47% +$2.09M ﹤0.01% 2414
2022
Q4
$4.38M Buy
343,856
+102,148
+42% +$919K ﹤0.01% 2733
2022
Q3
$1.4M Buy
241,708
+150,663
+165% +$662K ﹤0.01% 3225
2022
Q2
$293K Sell
91,045
-76,897
-46% -$232K ﹤0.01% 4042
2022
Q1
$633K Buy
167,942
+2,941
+2% +$18.9K ﹤0.01% 3822
2021
Q4
$2.16M Sell
165,001
-13,324
-7% -$211K ﹤0.01% 3334
2021
Q3
$3.49M Buy
178,325
+21,057
+13% +$385K ﹤0.01% 3124
2021
Q2
$2.94M Buy
157,268
+14,204
+10% +$317K ﹤0.01% 3150
2021
Q1
$3.39M Buy
143,064
+18,739
+15% +$433K ﹤0.01% 2976
2020
Q4
$3.03M Buy
124,325
+26,234
+27% +$671K ﹤0.01% 2861
2020
Q3
$2.52M Buy
98,091
+27,137
+38% +$861K ﹤0.01% 2756
2020
Q2
$1.41M Buy
70,954
+1,952
+3% +$47.4K ﹤0.01% 3022
2020
Q1
$1.74M Buy
69,002
+12,969
+23% +$379K ﹤0.01% 2742
2019
Q4
$1.47M Buy
+56,033
New +$1.56M ﹤0.01% 3134

Other funds holding ETNB

Geode Capital Management's ETNB Position: Q4 2025 in Review

Geode Capital Management sold out of 89bio (ETNB) in Q4 2025, closing a stake of 3,092,340 shares — an estimated $45.5M sold.

Geode Capital Management first reported a position in ETNB in Q4 2019 and held it in 24 quarters. The position peaked at $45.5M in Q3 2025. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.

  • Geode Capital Management reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
  • Geode Capital Management sold 3,092,340 89bio shares in Q4 2025, an estimated $45.5M.
  • Geode Capital Management first reported a position in 89bio in Q4 2019 and held it in 24 quarters.
  • Geode Capital Management's 89bio position peaked at $45.5M in Q3 2025.
  • 2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.

Based on Geode Capital Management's 13F filing for Q4 2025, filed 9 Feb 2026.